Yoshimi Noda

1.9k total citations
18 papers, 226 citations indexed

About

Yoshimi Noda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Yoshimi Noda has authored 18 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Yoshimi Noda's work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Yoshimi Noda is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Yoshimi Noda collaborates with scholars based in Japan. Yoshimi Noda's co-authors include Tomonori Hirashima, Naoko Morishita, Norio Okamoto, Ayako Tanaka, Kunimitsu Kawahara, Takayuki Shiroyama, Hidekazu Suzuki, Atsushi Kumanogoh, Takayuki Niitsu and Hidekazu Suzuki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BMC Infectious Diseases.

In The Last Decade

Yoshimi Noda

17 papers receiving 225 citations

Peers

Countries citing papers authored by Yoshimi Noda

Since Specialization

Citations

This map shows the geographic impact of Yoshimi Noda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Noda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Noda more than expected).

Fields of papers citing papers by Yoshimi Noda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Noda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Noda. The network helps show where Yoshimi Noda may publish in the future.

Co-authorship network of co-authors of Yoshimi Noda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Noda. A scholar is included among the top collaborators of Yoshimi Noda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Noda. Yoshimi Noda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Vasoprotective effects of lysophosphatidic acid inhibit vascular injury caused by SARS-CoV-2 infection 2025 ·Scientific Reports ·Fumitaka Muramatsu, (unknown), Tatsuya Suzuki, Teppei Shimamura, Yumiko Hayashi, Kazuhiro Takara, (unknown), (unknown), (unknown), Yoshimi Noda, Nobuyuki Takakura, Toru Okamoto, Hiroyasu Kidoya	0
2	Brain-derived endothelial cells are neuroprotective in a chronic cerebral hypoperfusion mouse model 2024 ·Communications Biology ·Yuichi Matsui, Fumitaka Muramatsu, Hajime Nakamura, Yoshimi Noda, Kinnosuke Matsumoto, Haruhiko Kishima, Nobuyuki Takakura	8
3	Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity 2022 ·BMC Infectious Diseases ·Yuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, (unknown), Yoshimi Noda, Yuichi Adachi, Takayuki Niitsu, (unknown), Kentaro Tanaka, Kiyoharu Fukushima, Saori Amiya, Reina Hara, Eri Oguro-Igashira, Takanori Matsuki, Haruhiko Hirata, Yoshito Takeda, Hiroshi Kida, Atsushi Kumanogoh, Shota Nakamura, Kiyoshi Takeda	28
4	Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer 2022 ·Scientific Reports ·Yoshimi Noda, Takayuki Shiroyama, Kentaro Masuhiro, Saori Amiya, Takatoshi Enomoto, Yuichi Adachi, Reina Hara, Takayuki Niitsu, Yujiro Naito, Kotaro Miyake, Shohei Koyama, Haruhiko Hirata, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	10
5	COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier 2022 ·SHILAP Revista de lepidopterología ·Takatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata, Saori Amiya, Yuichi Adachi, Takayuki Niitsu, Yoshimi Noda, Reina Hara, Kiyoharu Fukushima, Yasuhiko Suga, Kotaro Miyake, Shohei Koyama, Kota Iwahori, Izumi Nagatomo, Natsuko Tokuhira, Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh	10
6	COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation 2021 ·Respiratory Medicine Case Reports ·Yoshimi Noda, Takayuki Shiroyama, Saori Amiya, Yuichi Adachi, Takatoshi Enomoto, Reina Hara, Takayuki Niitsu, Kotaro Miyake, Haruhiko Hirata, Yoshito Takeda, Atsushi Kumanogoh	2
7	Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients 2021 ·Anticancer Research ·Tomonori Hirashima, Yoshimi Noda, Hidekazu Suzuki, (unknown), Ayako Tanaka, Naoko Morishita, (unknown), Kaori Iwata, (unknown), Norio Okamoto	8
8	Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19 2021 ·Respirology Case Reports ·Saori Amiya, Haruhiko Hirata, Takayuki Shiroyama, Yuichi Adachi, Takayuki Niitsu, Yoshimi Noda, Takatoshi Enomoto, Reina Hara, Kiyoharu Fukushima, Yasuhiko Suga, Kotaro Miyake, (unknown), Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh	14
9	Safety and efficacy of afatinib for the treatment of non-small-cell lung cancer following osimertinib-induced interstitial lung disease: A retrospective study 2020 ·Investigational New Drugs ·(unknown), Hidekazu Suzuki, Takayuki Shiroyama, Ayako Tanaka, (unknown), (unknown), Yoshimi Noda, Naoko Morishita, Norio Okamoto, Tomonori Hirashima	8
10	Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint Inhibitors 2020 ·Anticancer Research ·(unknown), Hidekazu Suzuki, Hiroko Yoshida, (unknown), (unknown), (unknown), Yoshimi Noda, (unknown), Ayako Tanaka, Naoko Morishita, Shoji Hashimoto, Kunimitsu Kawahara, Yoshitaka Tamura, Norio Okamoto, Toshio Tanaka, Tomonori Hirashima	17
11	The Association Between Extracellular Water-to-Total Body Water Ratio and Therapeutic Durability for Advanced Lung Cancer 2020 ·Anticancer Research ·Yoshimi Noda, Hidekazu Suzuki, (unknown), (unknown), (unknown), Ayako Tanaka, Naoko Morishita, Norio Okamoto, Tomonori Hirashima	22
12	Transbronchial Cryobiopsy for Miliary Tuberculosis Mimicking Hypersensitivity Pneumonitis 2020 ·Internal Medicine ·(unknown), Kunimitsu Kawahara, (unknown), Norio Okamoto, Yoshitaka Tamura, Hidekazu Suzuki, Takayuki Shiroyama, (unknown), (unknown), Yoshimi Noda, Ayako Tanaka, Naoko Morishita, Kayo Ueda, Shoji Hashimoto, Tomonori Hirashima, Takayuki Nagai	2
13	Development of Severe Heart Failure in a Patient with Squamous Non-small-cell Lung Cancer During Nivolumab Treatment 2020 ·Internal Medicine ·(unknown), (unknown), (unknown), Yoshimi Noda, (unknown), Ayako Tanaka, Naoko Morishita, Hidekazu Suzuki, Norio Okamoto, Hiroshi Harada, (unknown), Kayo Ueda, Kunimitsu Kawahara, Tomonori Hirashima	11
14	Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review 2020 ·Thoracic Cancer ·Takayuki Niitsu, Takayuki Shiroyama, Kotaro Miyake, Yoshimi Noda, (unknown), Reina Hara, Takatoshi Enomoto, Yuichi Adachi, Saori Amiya, Yasuhiko Suga, Kiyoharu Fukushima, Shohei Koyama, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	10
15	Invasive Tracheobronchial Aspergillosis with Bronchial Ulcers Complicated by Nontuberculous Mycobacterial Disease 2020 ·Internal Medicine ·(unknown), (unknown), Yoshimi Noda, Sungho Kim, (unknown), (unknown), (unknown), (unknown), Hiroshi Morishita, (unknown), Kunimitsu Kawahara, Takashi Yaguchi, Hiroto Matsuoka	1
16	The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors 2019 ·Anticancer Research ·Tomonori Hirashima, (unknown), Hidekazu Suzuki, Hiroko Yoshida, (unknown), (unknown), (unknown), Yoshimi Noda, (unknown), Ayako Tanaka, Naoko Morishita, Shoji Hashimoto, Kunimitsu Kawahara, Yoshitaka Tamura, Norio Okamoto, Toshio Tanaka	35
17	Comparison of the Utilities of Cryobiopsy and Forceps Biopsy for Peripheral Lung Cancer 2019 ·Anticancer Research ·(unknown), Norio Okamoto, Hidekazu Suzuki, Takayuki Shiroyama, Ayako Tanaka, (unknown), (unknown), Yoshimi Noda, (unknown), Naoko Morishita, Kayo Ueda, Kunimitsu Kawahara, Tomonori Hirashima	30
18	[A phase II study of UFT in non-small cell lung cancer]. 1986 ·PubMed ·Eiji Shimizu, Kazuhiro Kimura, S Sone, I Inoue, (unknown), Yoshimi Noda, Fumihiko Hojo, Masayuki Yagi, S. Nakanishi, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact